What documents does ShineHerb provide with each shipment?

Every batch ships with a Certificate of Analysis (COA). A technical specification sheet and MSDS are available on request, and HALAL, KOSHER, ISO and other certificate copies can be shared during supplier qualification.

Which quality standards do your ingredients follow?

Depending on the ingredient, products are tested against USP, EP, CP or FCC monographs, or against an agreed customer specification. Assay methods include HPLC, UV, GC and titration, and enzyme activity is reported in the unit system used by the relevant monograph.

Can I request a sample before placing a bulk order?

Yes. Samples are available for most catalog ingredients so your QC team can verify identity, assay and solubility before a purchase decision. Contact the sales team with the product name, grade and intended application.

Do you support custom specifications or OEM formulas?

Yes. Extract ratios, standardization levels, mesh size, enzyme activity and packaging can be adjusted for many products, and the team supports custom formulas for supplement and cosmetic brands.

Where is ShineHerb Biotech located and which markets do you serve?

ShineHerb Biotech is based in the Hi-Tech Zone of Xi'an, Shaanxi Province, China, and supplies buyers in Europe, North America, Southeast Asia and the Middle East.

High-Quality Bifidobacterium infantis Freeze‑Dried Powder Suppliers & Companies

Featured Active Portfolio

High-Purity Bio-Ingredients & Core Supply Catalog

Direct factory inventory spanning stabilized clinical intermediates, enzymatic building blocks, and standardized plant derivatives for global formulators.

High-Quality Hot Sale Citric Acid Monohydrate CAS 5949-29-1 Acid Condiment Exporters, Exporter

High-Quality 100% Natural Phosphatidylserine Powder Pure Soybean Extract supplier Suppliers, Factories

Best Wholesale 99% Pterostilbene Powder CAS 537-42-8 Trans-Pterostilbene Antioxidant Supplement Raw Material Manufacturer, Factory

Wholesale Thiamine (Vitamin B1) Powder Supplier High purity raw material Supplier, Factories

China Natural Plant Extract Berberine HCl 97% Berberine Sulfate 98% Supplier, Companies

Wholesale Bulk Natural Ecdysterone / 20-Hydroxyecdysone Raw Material for Sports Supplements Companies, Exporters

China Argireline Peptide Anti-Wrinkle Ingredient for Cosmetic Ingredient Manufacturer, Exporter

China High quality Dihydromyricetin Powder supplier Vine Tea Extract for Liver health Manufacturers, Factory

Scientific Landscape & Global Viability

Commercial Status of Bifidobacterium infantis Freeze-Dried Powder

Deconstructing the biological uniqueness, enzymatic machinery, and pharmaceutical demand driving the rapid adoption of specialized infantis strains.

Unique HMO Metabolism Engine

Unlike standard gut commensals, Bifidobacterium longum subsp. infantis possesses a dedicated 43-kb gene cluster dedicated to internalizing and hydrolyzing Human Milk Oligosaccharides (HMOs). By utilizing intracellular endo-alpha-N-acetylgalactosaminidase and sialidases, it completely metabolizes 2'-fucosyllactose (2'-FL) and lacto-N-neotetraose (LNnT) without cross-feeding pathogenic opportunistic bacteria.

Biochemical Superiority

Global Pediatric Shortage

Epidemiological screening indicates that over 90% of infants born via cesarean delivery or prescribed perinatal antibiotics in Western and East Asian nations lack functional gut colonization of B. infantis. This persistent colonization deficit directly correlates with escalating pediatric atopic dermatitis, systemic gut dysbiosis, and compromised mucosal IgA development.

Clinical Necessity

Lyophilization Cryo-Tolerance

As an obligate anaerobe, B. infantis is exceptionally susceptible to oxygen toxicity and osmotic cell rupture during primary sublimation. Premium suppliers utilize cutting-edge membrane vitrification technologies and high-viability cryogenic matrices, sustaining stable potencies exceeding 1.0 × 10¹¹ to 5.0 × 10¹¹ CFU/g over 24-month stability profiles.

Bio-Engineering

E-E-A-T Technical Benchmark: Sourcing high-grade Bifidobacterium infantis requires strict genetic discrimination from standard Bifidobacterium longum subsp. longum. Contract manufacturing specifications must demand whole-genome sequencing (WGS) data verifying the H1-H5 HMO-utilization transport cassette to guarantee authentic functional clinical performance.

Manufacturing Economics & Infrastructure

China Factory Efficiency & Bioprocess Advantages

How state-of-the-art Chinese fermentation bio-foundries drive unmatched cost-performance, high-density yields, and global regulatory compliance.

Multi-Stage Microencapsulation

Chinese biomanufacturing plants employ patented double-layer embedded microencapsulation (enteric sodium alginate combined with marine collagen peptides). This robotic coating process shields cellular membranes against stomach gastric acids (pH 1.5–2.0) and bile salts, achieving intestine delivery survival rates >88%.

Process Innovation

Industrial Anaerobic Fermentation

Utilizing 50,000-liter automated anaerobic fermenters equipped with continuous optical density feedback loops and micro-gas chromatography monitoring, facilities in Shaanxi maximize high-density cell mass yield per batch while maintaining razor-sharp thermal dissipation.

Scaling Capacity

Cryoprotectant Engineering

By substituting generic maltodextrin with specialized high-solubility trehalose, fructooligosaccharides (FOS), and antioxidant sodium erythorbate formulas, our freeze-drying matrices suppress cellular eutectic shock during rapid ice crystal formation below -50°C.

Cryo-Formulation

Full Regulatory Dossier Backing

Domestic industrial clusters operate in complete compliance with cGMP, ISO 22000, FSSC 22000, HALAL, and Kosher mandates. Complete non-GMO documentation, heavy metal quantification (ICP-MS), and multi-point pathogenic screening accompany every containerized release.

Supply Chain Safety

500B+

CFU/g Max Concentrated Potency

< 3.0%

Residual Water Content (Karl Fischer)

24 Mo.

Room Temp Ambient Stability Profile

100%

Genotypic Identification (16S rRNA / WGS)

Analytical Specifications

Standard Grade vs. Pharmaceutical-Grade B. infantis Freeze-Dried Powder

A granular look at the critical chemical, biological, and physical parameters governing high-performance contract manufacturing.

Analytical Parameter	Commercial Dietary Grade	High-Potency Pharma / Clinical Grade	Testing Monograph / Methodology
Viable Cell Count (CFU/g)	5.0 × 10¹⁰ to 1.0 × 10¹¹	2.0 × 10¹¹ to 5.0 × 10¹¹	ISO 29981 / IDF 220 Anaerobic Plate Count
Microencapsulation Efficiency	Single-matrix spray/lyophilized (≤ 65%)	Double-coat enteric core-shell (> 88%)	In Vitro Gastric Fluid (USP Simulated pH 1.8)
Water Activity (aw)	≤ 0.15 aw	≤ 0.08 aw	Chilled Mirror Dew Point Sensor (USP <922>)
Moisture Content (%)	≤ 5.0%	≤ 2.5%	Karl Fischer Coulometric Titration
Lead (Pb) / Arsenic (As)	≤ 1.0 ppm / ≤ 1.0 ppm	≤ 0.1 ppm / ≤ 0.1 ppm	ICP-MS (Inductively Coupled Plasma Mass Spec)
Coliforms & Enterobacteriaceae	< 10 CFU/g	Negative / 10g	USP <2021> / ISO 21528-2
HMO Cleavage Cluster Confirmation	Optional / Unverified	100% Sequence Identity (H1-H5 clusters)	Illumina NovaSeq NGS Whole-Genome Mapping

Downstream Formulations

Localized Industry Application Scenarios

From infant formulas to metabolic therapies, discovering where bulk B. infantis powders generate clinical value and strong retail margins.

Pediatric Infant Stage-1 & 2 Formulations

Synergistically dry-blended with 2'-FL (fucosyllactose) and GOS (galactooligosaccharides) to recreate human colostrum gut colonizing capacity. Restores the dominance of healthy bifidobacteria, dramatically lowering fecal calprotectin in preterm infants.

Infant Nutrition

Clinical Gastroenterology Supplements

High-dose delayed-release capsules designed to alleviate severe symptoms of Irritable Bowel Syndrome (IBS), Ulcerative Colitis, and post-infectious bowel inflammation by modulating anti-inflammatory cytokine expression (elevating IL-10 / downregulating TNF-alpha).

Gastro Therapeutics

Dermatology & Anti-Atopic Solutions

Leveraging gut-skin axis communications, pharmaceutical formulations pairing B. infantis powder with specialized antioxidants help reduce clinical severity indices (SCORAD) in children suffering from chronic eczema and hyper-allergenic immune responses.

Nutricosmetics

Functional Probiotic Chewables & Sticks

Stable freeze-dried powders customized for direct dissolution in sachet sticks, water-free orally disintegrating tablets (ODTs), and low-water active functional gummies utilizing clean-label prebiotics such as isomalt and resistant dextrin.

Fast-Moving Consumer

Market Dynamics & Future Outlook

Evolving Industry Trends & Procurement Drivers

Crucial shifts in global supply chain risk management, strain level differentiation, and regulatory gatekeeping.

Shift from Species to Strain-Level Provenance

Procurement directors at multi-national healthcare corporations no longer purchase generic Bifidobacterium infantis. Demand requires documented deposition in international strain depositories (such as ATCC, DSMZ, or CGMCC), accompanied by randomized, double-blind, placebo-controlled clinical trials (RCTs) proving safety and efficacy.

Procurement Shift

Non-Dairy & Hypoallergenic Culture Media

To supply severe dairy-allergic populations (infants with CMPA - Cow's Milk Protein Allergy), top-tier Chinese fermentation enterprises have eliminated traditional dairy-based peptonized culture media. They utilize certified allergen-free plant-based peptones derived from pea or non-GMO soy, meeting strict zero-casein thresholds.

Allergen Safety

Clean-Label Ambient Stability Demand

The global shipping crisis highlighted the volatility of uninterrupted cold-chain logistics. Procurement teams actively seek high-potency freeze-dried matrices capable of withstanding ambient maritime freight across equatorial zones without shedding more than 0.2 log loss CFU over transit periods.

Logistics Engineering

Procurement & Technical Q&A

Frequently Asked Questions by Global Buyers

Clear, direct answers regarding stability, quality assurance, regulatory certificates, and factory audits.

How does your factory confirm identity between B. infantis and B. longum?

We deploy full Whole-Genome Sequencing (Illumina paired-end reads) and targeted PCR verification to confirm the presence of the B. infantis unique HMO-utilization gene cluster (sialidases, fucosidases, and naglu genes). Every batch of parent seed culture is cross-verified against its international depository reference.

What is the standard packaging to preserve anaerobic viability during ocean freight?

Our freeze-dried powders are hermetically heat-sealed in pharmaceutical-grade multi-layer aluminum foil bags (composed of PET/AL/NY/PE layers) with internal food-grade desiccants and ultra-pure nitrogen flush (< 0.5% residual oxygen). Shipments are cushioned in heavy-duty fiber drums and shipped via reefer containers or temperature-controlled air freight.

Can you provide customized strain concentrations for direct-compression tablets?

Yes. In addition to high-potency concentrates (e.g., 200B–500B CFU/g), we formulate standardized blends at 10B, 50B, or 100B CFU/g utilizing specified excipients such as microcrystalline cellulose (MCC), maltodextrin, or organic inulin. We can optimize particle mesh size to prevent shear-induced cell death during tablet compression.

What third-party documentation is delivered prior to commercial customs clearance?

Every commercial batch is supplied with an exhaustive Certificate of Analysis (COA) containing exact CFU plating counts, water activity, Karl Fischer moisture, ICP-MS heavy metals, microbiological absence checks (Salmonella, E. coli, Staph aureus), non-irradiated certificates, TSE/BSE statements, and country-of-origin veterinary health documentation.

Comprehensive Raw Materials Directory